Funding for this research was provided by:
Akcea Therapeutics
Article History
Received: 3 August 2022
Accepted: 19 December 2022
First Online: 26 January 2023
Declarations
:
: All participants provided written informed consent to take part in the study.
: Not applicable.
: SHP is a former employee of Akcea Therapeutics, Inc. SA is an employee and shareholder of Acaster Lloyd Consulting Ltd. SHL is an employee of Acaster Lloyd Consulting Ltd. Acaster Lloyd Consulting Ltd were commissioned by Akcea Therapeutics, Inc. to conduct the study.